Search for: All records

Elucidation of maize strigolactone biosynthetic pathway has the potential for controlling the parasitic witchweed Striga . 

Arnold, J. E., Mayo, H., & Dong, L. (2020). Individual differences (or the lack of them) in comprehension of singular they. Technical Report #3. UNC Language Processing Lab, Department of Psychology & Neuroscience, University of North Carolina – Chapel Hill, Chapel Hill, North Carolina. The pronoun “they” can refer to an individual who identifies as nonbinary, but it also is commonly used as a plural pronoun. How do listeners identify whether “they” is being used in a singular or plural sense? Arnold, Mayo, & Dong (in press) report three experiments in that test the role of explicitly introducing gender identity via pronouns, e.g. “This is Alex, and they use they/them pronouns.” Participants read short stories like “Alex went running with Liz and they fell down.” Answers to “Who fell down” indicated whether participants interpreted they as Alex or Alex-and-Liz. Singular interpretations of they were more likely when participants hear an explicit statement that Alex uses they/them pronouns, and in supporting discourse contexts. This paper is a companion to the main article, and reports analyses of individual difference measures. Participants self-reported familiarity with individuals who identify as nonbinary, which was expected to increase singular interpretations, but mostly it did not. In experiment 2 we also measured print exposure, but we found that it did not affect interpretation of singular they. In short, we saw virtually no effects of individual difference predictors. 

Acute injury to aged individuals represents a significant challenge to the global healthcare community as these injuries are frequently treated in a reactive method due to the infeasibility of frequent visits to the hospital for biometric monitoring. However, there is potential to prevent a large number of these cases through passive, at-home monitoring of multiple physiological parameters related to various causes that are common to aged adults in general. This research strives to implement wearable devices, ambient “smart home” devices, and minimally invasive blood and urine analysis to test the feasibility of implementation of a multitude of research-level (i.e. not yet clinically validated) methods simultaneously in a “smart system”. The system comprises measures of balance, breathing, heart rate, metabolic rate, joint flexibility, hydration, and physical performance functions in addition to lab testing related to biological aging and mechanical cell strength. A proof-of-concept test is illustrated for two adult males of different ages: a 22-year-old and a 73-year-old matched in body mass index (BMI). The integrated system is test in this work, a pilot study, demonstrating functionality and age-related clinical relevance. The two subjects had physiological measurements taken in several settings during the pilot study: seated, biking, and lying down. Balance measurements indicated changes in sway area of 45.45% and 25.44%, respectively for before/after biking. The 22-year-old and the 73-year-old saw heart rate variabilities of 0.11 and 0.02 seconds at resting conditions, and metabolic rate changes of 277.38% and 222.23%, respectively, in comparison between the biking and seated conditions. A smart camera was used to assess biking speed and the 22- and 73-year-old subjects biked at 60 rpm and 28.5 rpm, respectively. The 22-year-old subject saw a 7 times greater electrical resistance change using a joint flexibility sensor inside of their index finger in comparison with the 73-year-old male. The 22 and 73-year-old males saw respective 28% and 48% increases in their urine ammonium concentration before/after the experiment. The average lengths of the telomere DNA from the two subjects were measured to be 12.1 kb (22-year-old) and 6.9 kb (73-year-old), consistent with their biological ages. The study probed feasibility of 1) multi-metric assessment under free living conditions, and 2) tracking of the various metrics over time. 

The superτ-charm facility (STCF) is an electron–positron collider proposed by the Chinese particle physics community. It is designed to operate in a center-of-mass energy range from 2 to 7 GeV with a peak luminosity of 0.5 × 10³⁵cm⁻²·s⁻¹or higher. The STCF will produce a data sample about a factor of 100 larger than that of the presentτ-charm factory — the BEPCII, providing a unique platform for exploring the asymmetry of matter-antimatter (charge-parity violation), in-depth studies of the internal structure of hadrons and the nature of non-perturbative strong interactions, as well as searching for exotic hadrons and physics beyond the Standard Model. The STCF project in China is under development with an extensive R&D program. This document presents the physics opportunities at the STCF, describes conceptual designs of the STCF detector system, and discusses future plans for detector R&D and physics case studies.

 

The analysis of membranous extracellular vesicles, such as exosomes vesicles (EV) opens a new direction for the rapid disease diagnosis because EVs can carry molecular constituents of their originating cells. Secreted by mammalian cells, the size of most membrane-bound phospholipid EVs ranges from 50 to 150 nm in diameter. Recent studies have demonstrated the potential of using EVs for cancer diagnosis and treatment monitoring. To diagnose infectious diseases using EVs, the ability to discriminate EVs from host cells and parasites is key. Here, we report a rapid EV analysis assay that can discriminate EVs based on a host-specific transmembrane protein (CD63 antigen) using a label-free optical biosensor. 

The optical resonances of the silicon nanopost array patterned on a silicon-on-insulator (SOI) substrate have been investigated. The fabricated device supports optical resonances in the range of 1.55 μm with a variable Q factor depending on the angle of incidence. By sealing the device on top of the nanoposts, we demonstrated a lateral flow-through label-free biosensor built on SOI. The biosensor exhibits the refractive index sensitivity of 800 nm/RIU and the femtomolar sensitivity for detection of a breast cancer biomarker (ErbB2).